Results 91 to 100 of about 9,257 (139)

Resistance of Gram-Negative Bacteria to Cefepime-Enmetazobactam: A Systematic Review

open access: yesPathogens
Cefepime-enmetazobactam is a novel β-lactam/β-lactamase inhibitor combination showing good activity against multidrug-resistant (MDR) Gram-negative bacteria producing a variety of β-lactamases.
Matthew E. Falagas   +4 more
doaj   +1 more source

Structure, function, and evolution of metallo-β-lactamases from the B3 subgroup-emerging targets to combat antibiotic resistance. [PDF]

open access: yesFront Chem, 2023
Krco S   +9 more
europepmc   +1 more source

Correction: 2-Mercaptomethyl-thiazolidines use conserved aromatic-S interactions to achieve broad-range inhibition of metallo-β-lactamases. [PDF]

open access: yesChem Sci, 2023
Rossi MA   +13 more
europepmc   +1 more source

Characterization of two novel VIM-type metallo-β-lactamases, VIM-84 and VIM-85, associated with the spread of IncP-2 megaplasmids in Pseudomonas aeruginosa. [PDF]

open access: yesMicrobiol Spectr, 2023
Wang N   +12 more
europepmc   +1 more source

A STUDY OF METALLO-BETA-LACTATAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN CLINICAL SAMPLES OF S.S.G. HOSPITAL

open access: yesNational Journal of Medical Research, 2011
Introduction: Pseudomonas spp. is common pathogen causing nosocomial infection. Acquired drug resistance is frequent in nosocomial isolates of Pseudomonas spp. Acquired metallo-β-lactamases (MBL) in pseudomonas spp.
Mehul S Chaudhari   +4 more
doaj  

First report of SPM metallo-β-lactamases producing Acinetobacter baumannii isolates in Morocco. [PDF]

open access: yesIran J Microbiol, 2022
Massik A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy